Drug intelligence / Profile preview

Passiflora Curarina

Development stage
Unknown
Lead developer
Harras Pharma Curarina
Modality
Small Molecules
Administration
Oral
01

Overview

Passiflora Curarina is a herbal medicinal product developed and marketed by Harras Pharma, a German pharmaceutical company. The product contains a highly concentrated fluid extract of passionflower (*Passiflora incarnata*). It is primarily indicated for the treatment of nervous restlessness and symptoms of nervous stress. A specific variant, Passiflora night Curarina, is used as a traditional herbal medicine to improve well-being during stressful periods and to promote sleep. These products are 100% plant-based, contain pure passionflower extract without additives, and are available exclusively in pharmacies in Germany. Harras Pharma combines traditional medicinal plant knowledge with modern pharmaceutical research to produce these highly concentrated extracts.

Brand names
Passiflora CurarinaPassiflora night Curarina
Other names
Passiflora Harras PharmaPassionflower extract
02

Targets

GABA-B (Gamma-aminobutyric acid receptor type B)

Beyond the preview

Go deeper on Passiflora Curarina.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Passiflora Curarina.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call